Skip Navigation



JAC Advance Access published online on March 3, 2004
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkh145
© 2004 by The British Society for Antimicrobial Chemotherapy
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
53/4/653    most recent
dkh145v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Vereshchagin, V. A.
Right arrow Articles by Govorun, V. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vereshchagin, V. A.
Right arrow Articles by Govorun, V. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 The British Society for Antimicrobial Chemotherapy

Brief report

Fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Russia: molecular mechanisms implicated

V. A. Vereshchagin 1 *, E. N. Ilina 1 , M. V. Malakhova 1 , M. M. Zubkov 2 , S. V. Sidorenko 3 , A. A. Kubanova 2 , and V. M. Govorun 1

1 Institute of Physico-Chemical Medicine, Malaya Pirogovskaya st., 1a, 119992, Moscow;
2 Central Research Institute of Dermatology and Venereology, Moscow;
3 National Research Centre for Antibiotics, Moscow, Russia

* Corresponding author. E-mail: vereshchagin{at}nm.ru.

Received 27 October 2003 ; revised 14 January 2004 ; accepted 15 January 2004

Abstract

Objectives: During a longitudinal study of the prevalence of antimicrobial resistance in Neisseria gonorrhoeae, a number of high-level fluoroquinolone-resistant isolates were obtained from the sexually transmitted diseases clinic in the Moscow region in 2002. The aim of the present study was to determine the molecular mechanisms of resistance and to assess the clonal relationship of these strains

Methods: For the 32 clinical strains of N. gonorrhoeae studied, the MIC values were determined for four fluoroquinolones. The gyrA, parC, por and mtrR genes were studied for the presence of mutations associated with fluoroquinolone resistance.

Results: We detected strains of N. gonorrhoeae showing high-level resistance to fluoroquinolones (21 strains, with MICs 1-32 mg/L). Mutations in gyrA and parC known to cause fluoroquinolone resistance were detected in a majority of strains. There were four strains (among 21) without known changes in gyrA and parC. However, amino acid changes in the Por protein and mutations in the promoter or encoding region of the mtrR gene were detected in three of them. One strain had no alteration in gyrA, parC, por or mtrR.

Conclusions: The present study documents the first case of fluoroquinolone-resistant N. gonorrhoeae in Russia.

Keywords: N. gonorrhoeae, fluoroquinolones, mechanisms of resistance
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Sex. Transm. Infect.Home page
M Unemo, A Savicheva, O Budilovskaya, E Sokolovsky, M Larsson, and M Domeika
Laboratory diagnosis of Neisseria gonorrhoeae in St Petersburg, Russia: inventory, performance characteristics and recommended optimisations
Sex Transm Inf, February 1, 2006; 82(1): 41 - 44.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.